A Phase 3 Study to Evaluate the Safety of Sotagliflozin in Patients With Type 1 Diabetes Who Have Inadequate Glycemic Control With Insulin Therapy Alone

Clinical trial NCT02531035 · COMPLETED

Trial details

NCT number: NCT02531035
Sponsor: Lexicon Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus (T1DM)High Level of Sugar (Glucose) in the Blood

Start date: 2015-09-01
Primary completion: 2017-04-01
Enrollment: 1405

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.